𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is 18F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?

✍ Scribed by Ludger Staib; Holger Schirrmeister; Sven Norbert Reske; Hans Günther Beger


Book ID
117023095
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
197 KB
Volume
180
Category
Article
ISSN
0002-9610

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Clinical value of whole-body positron em
✍ G. Beets; Professor F. Penninckx; C. Schiepers; L. Filez; L. Mortelmans; R. Kerr 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

## Abstract To assess the clinical value of whole-body positron emission tomography (PET) with [18F]fluorodeoxyglucose (FDG) in recurrent colorectal cancer, 35 patients were studied: 15 had resectable liver metastases, one a resectable lung metastasis, eight resectable pelvic recurrence, eight a pr

Is 18F-fluorodeoxyglucose positron emiss
✍ Laurent Arnaud; Julien Haroche; Zoulikha Malek; Frédérique Archambaud; Laetitia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 2 views

## Abstract ## Objective ^18^F‐fluorodeoxyglucose–positron emission tomography (FDG‐PET) scanning has been proposed as a new way of assessing disease activity in Takayasu arteritis (TA), but previous studies have used the nonvalidated National Institutes of Health (NIH) global activity criteria, a